iBOT uses a sophisticated array of sensors and gyroscopes to perform its feats, which include balancing on two of its four wheels to raise users to standing height.

While iBOT technology is heralded as revolutionary, it won’t be a simple matter for consumers to get their butts on one. First, the FDA has declared the wheelchair will require a doctor's prescription and special training to drive. This is because it requires some user exertion and ability. People must have the use of at least one arm to operate the iBOT's controls. They must also have the ability to lean forward or backward. And they must be able to hold onto a stair rail to help guide the iBOT up and down steps.

Then there is the matter of cost. The iBOT price tag is quite hefty, and insurers are not jumping on board to cover the costs. In 2005, the U.S. Veterans Health Administration (VHA) approved coverage of the iBot 4000.  Independence Technology says it is still negotiating with other insurers, but hasn’t indicated if insurance support is likely.

All this means that it’s unlikely you’ll see the iBOT available in Canada anytime soon.  Independence Technology also introduced the iGLIDE® Manual Assist Wheelchair in the U.S. in January 2003, but has since ceased selling it to focus on the iBOT Mobility System.

The iBOT is the brainchild of inventor Dean Kamen, whose other credits include the Segway transporter. Kamen licensed the iBOT technology to Johnson & Johnson.